Novus Therapeutics Inc (NVUS)

Health Care > Major Pharmaceuticals

Price

  • Last Close
  • $ 14.69
    -0.59
  • Trading Volume
  • 56,441
  • Market Cap
  • $ 150.9M
  • 52-Week High/Low
  • 26.18 - $13.81

Earnings

  • Earning
  • 2020 2021
    $ 0 -
  • 2021 P/E Ratio
  • Trailing Forward
    0 -
  • Short share
  • Date Shares Ratio
    Sep 30, 2019 28794 0.31

Gain

  • 30-day
  • NVUS 0%
    S&P 500 4.06%
  • 90-day
  • 0%
  • 3.87%
  • 180-day
  • 0%
  • 8.42%
  • 52-Week
  • -7.14%
  • 31.69%

Dividend

  • Dividend
  • 0
  • Dividend Yield
  • ;0%
  • Outstanding
  • 9,434,240
  • 50 Day Avg Volume
  • 37452

Calender

  • Fiscal Year End
  • Dec 31
  • Last Earning Date
  • Nov 16, 2020
  • Ex-Dividend Date
  • -
  • Current Year Beta
  • 0.68

Ratio

  • Debt To EQuity
  • 0
  • Return On Equity
  • -97.05%
  • Book Value
  • $1.61

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Q1 0 0 -0.5 -0.4 0 0.5 0.6 -88.1 0 0
Q2 0 0 -0.4 -0.3 1.3 0.6 0.4 -105.1 0 0
Q3 0 0 -0.2 -0.4 0.4 0.4 0.5 -24.4 -61.4 0
Q4 0 0 0 -0.5 0.1 0 0.5 185.2 0 0
A 0 0 -1.1 -1.6 1.8 1.5 2 -32.4 -342.2 -279.8

Dividend
+

Q1
Q2
Q3
Q4
A

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 3.8% -33.9% 151.3% 24.1% - - - - - - -
Q2 - 17.5% -76% 47.7% -8.3% - - - - - -
Q3 - 107.2% -30.2% -33.2% -10.9% - - - - - -
Q4 - 1521.1% -12.9% -64.9% -22.7% - - - - - -

Returns +
M

J F M A M J J A S O N D
2021 3.8% - - - - - - - - - - -
2020 -0.3% -6.5% -29.1% 77.6% 83.4% -63.9% -0.7% -7.5% 125.7% 2655.8% -6.7% -37%

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
NVUS 4%2510%-63%-61%0%0%0%0%0%0%0%

Annual
Returns

52 Week
High/Low

Earnings

Chart